(Q37790215)

23 August 2017

title

Midterm experience with implantable cardioverter-defibrillators in children and young adults (English)

1 reference

23 August 2017

1 reference

Alpay Çeliker

1

1 reference

23 August 2017

Haşim Olgun

2

1 reference

23 August 2017

Tevfik Karagoz

3

1 reference

23 August 2017

Sema Özer

4

1 reference

23 August 2017

Süheyla Özkutlu

5

1 reference

23 August 2017

Dursun Alehan

6

1 reference

23 August 2017

publication date

18 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

1732-1738

1 reference

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Defibrillators in nonischemic cardiomyopathy treatment evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Implantable cardioverter-defibrillator therapy in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Potential benefit from implantable cardioverter-defibrillator therapy in children and young adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Implantable cardioverter defibrillator implantation in children in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Implantable cardioverter defibrillator (ICD) in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

ICD therapy in children and young adults: low incidence of inappropriate shock delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

Patient- and lead-related factors affecting lead fracture in children with transvenous permanent pacemaker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ340

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUQ340

1 reference

23 August 2017

1 reference